▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

JinkoSolar Holding Q4 22 Earnings Conference Call At 7:30 AM ET

By RTTNews Staff Writer ✉ | Published: 3/10/2023 7:00 AM ET

JinkoSolar Holding Co., Ltd. (JKS) will host a conference call at 7:30 AM ET on March 10, 2023, to discuss Q4 22 earnings results.

To access the live webcast, log on to http://www.jinkosolar.com

For a replay call, dial +1 855 883 1031 (US) or +61 7 3107 6325 (International), Passcode 10029354.

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In March 2023

Latest Updates on COVID-19

FDA Approves Pfizer's COVID-19 Pill Paxlovid

US Revokes Covid Vaccination Requirement For International Air Travel

SD Biosensor Recalls Certain COVID-19 At-Home Tests Distributed By Roche

Read More

COVID-19: Drugs in Development

RELATED NEWS

JinkoSolar Unit Jiangxi Jinko Signs Investment Framework Deal; To Sell Xinjiang Jinko

JinkoSolar Holding Co., Ltd. Q1 Profit Advances

Jinko Solar Announces Estimates Of Preliminary Q1 Results

JinkoSolar Holding Q4 22 Earnings Conference Call At 7:30 AM ET

JinkoSolar Holding Co., Ltd. Reports Climb In Q4 Bottom Line

Follow RTT

Editor's Pick
Most Read
Most Emailed

Chervon Recalls EGO Power+ Cordless Brushless Hedge Trimmers

E.N.A. Meat Packing Recalls Frozen, Raw Lamb Products

Macy's, Dollar General Q1 Profits Decline

FDA Warns Retailers Against Illegal Sales Of Disposable E-cigarettes

Tillamook Recalls Certain Waffle Cone Swirl Ice Cream Packaged In Chocolate Peanut Butter Carton

Mattel Unveils New Barbie The Movie Collection

Rudolph's OnYums Onion Flavored Rings Sold At Dollar Tree Recalled

Krispy Kreme, Dunkin' To Offer Free Donuts On National Doughnut Day

Cricket Creek Farm Recalls Sophelise And Tobasi Cheeses

Carvana Up 12%; Gets 'notable S&P Global Ratings Upgrades"

Pfizer Says Pivotal Phase 3 BASIS Clinical Trial Of Marstacimab Met Primary Endpoints

U-Haul Holding Shares Down On Lower Earnings In Q4

Seagen To Be Acquired By Pfizer For $43 Bln

AbbVie Says Upadacitinib 30 Mg Meets Primary Goals In SLE Patients In Mid-stage Study

Sanofi: Frexalimab Phase 2 Trial Meets Primary Goal In Relapsing Multiple Sclerosis

Magnachip To Spin-off Display And Power Businesses Into Separate Entities

Macy's Q1 Profit Down, But Beats Estimates; Cuts Annual Earnings Guidance Below View - Update

Atea Pharma Rejects Unsolicited Proposal From Tang Capital Partners

Trevena Achieves Listing Compliance On Nasdaq

ACI Worldwide Appoints Thomas Warsop As New CEO

Alterity Therapeutics Granted Initial Approval For Phase 2 Clinical Trial Of ATH434

Sanofi: Frexalimab Phase 2 Trial Meets Primary Goal In Relapsing Multiple Sclerosis

NatWest Completes Sale Of EUR 55.2 Mln Of Shares In Permanent TSB

Atea Pharma Rejects Unsolicited Proposal From Tang Capital Partners

Dollar General Q1 Results Miss Estimates, Cuts FY23 View; Stock Down In Premarket

Balfour Beatty's JV Gammon Bags HK$3.7 Bln Contract In Hong Kong

JBT To Sell Its AeroTech Business To Oshkosh - Quick Facts

Advance Auto Parts Announces Retreat In Q1 Bottom Line

AbbVie Says Upadacitinib 30 Mg Meets Primary Goals In SLE Patients In Mid-stage Study

Chewy Q1 Results Beat Estimate; Shares Jump 11% After Hours

Dollar General Down In Pre-market On Q1 Results, Outlook

Macy's, Dollar General Q1 Profits Decline

TotalEnergies Renews OML130 Deep Offshore License In Nigeria